XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.2
DERIVATIVES (Tables)
6 Months Ended
Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments by Category
The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments.
Derivative Instruments by Category
 
At June 30, 2019
 
Gains (Losses) Reported in Net Income (Loss) Six Months Ended June 30, 2019
 
 
 
Fair Value
 
 
Notional
Amount
 
Asset
Derivatives
 
Liability
Derivatives
 
 
(in millions)
Freestanding Derivatives (1) (2):
 
 
 
 
 
 
 
Equity contracts:
 
 
 
 
 
 
 
Futures
$
6,446

 
$

 
$

 
$
(930
)
Swaps
9,474

 
18

 
164

 
(1,260
)
Options
48,121

 
3,915

 
1,442

 
1,276

Interest rate contracts:
 
 
 
 
 
 
 
Swaps
26,896

 
1,133

 
238

 
1,597

Futures
12,718

 

 

 
25

Swaptions
2,746

 
52

 

 
7

Credit contracts:
 
 
 
 
 
 
 
Credit default swaps
1,232

 
22

 

 
13

Other freestanding contracts:
 
 
 
 
 
 
 
Foreign currency contracts
1,412

 

 
15

 
(27
)
Margin

 
36

 

 

Collateral

 
10

 
3,281

 

 
 
 
 
 
 
 
 
Embedded Derivatives (2):
 
 
 
 
 
 
 
GMIB reinsurance contracts

 
2,196

 

 
217

GMxB derivative features liability (3)

 

 
6,749

 
(1,116
)
SCS, SIO, MSO and IUL indexed features (4)

 

 
2,233

 
(1,535
)
Total
$
109,045

 
$
7,382

 
$
14,122

 
$
(1,733
)

______________
(1)
Reported in Other invested assets in the consolidated balance sheets.
(2)
Reported in Net derivative gains (losses) in the consolidated statements of income (loss).
(3)
Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.
(4)
SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets.
 
At December 31, 2018
 
Gains (Losses) Reported in Net Income (Loss) Six Months Ended June 30, 2018
 
 
 
Fair Value
 
 
Notional
Amount
 
Asset
Derivatives
 
Liability
Derivatives
 
 
(in millions)
Freestanding Derivatives (1) (2):
 
 
 
 
 
 
 
Equity contracts:
 
 
 
 
 
 
 
Futures
$
10,411

 
$

 
$

 
$
(276
)
Swaps
7,697

 
140

 
168

 
(49
)
Options
21,698

 
2,119

 
1,163

 
233

Interest rate contracts:
 
 
 
 
 
 
 
Swaps
27,003

 
632

 
194

 
(515
)
Futures
11,448

 

 

 
109

Credit contracts:
 
 
 
 
 
 
 
Credit default swaps
1,282

 
17

 

 
(2
)
Other freestanding contracts:
 
 
 
 
 
 
 
Foreign currency contracts
2,097

 
27

 
14

 
13

Margin

 
7

 
5

 

Collateral

 
3

 
1,564

 

 
 
 
 
 
 
 
 
Embedded Derivatives (2):
 
 
 
 
 
 
 
GMIB reinsurance contracts

 
1,991

 

 
(1,233
)
GMxB derivative features liability (3)

 

 
5,431

 
928

SCS, SIO, MSO and IUL indexed features (4)

 

 
687

 
(310
)
Total
$
81,636

 
$
4,936

 
$
9,226

 
$
(1,102
)
______________
(1)
Reported in Other invested assets in the consolidated balance sheets.
(2)
Reported in Net derivative gains (losses) in the consolidated statements of income (loss).
(3)
Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.
(4)
SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets.
Offsetting Financial Assets and Liabilities and Derivative Instruments
The following table presents information about the Company’s offsetting financial assets and liabilities and derivative instruments at December 31, 2018.
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At December 31, 2018
 
Gross Amount Recognized
 
Gross Amount Offset in the Balance Sheets
 
Net Amount Presented in the Balance Sheets
 
(in millions)
Assets:
 
 
 
 
 
Total derivatives
$
2,946

 
$
2,912

 
$
34

Other financial instruments
1,520

 

 
1,520

Other invested assets
$
4,466

 
$
2,912

 
$
1,554

Liabilities:
 
 
 
 
 
Total derivatives
$
3,109

 
$
2,912

 
$
197

Other financial liabilities
1,263

 

 
1,263

Other liabilities
$
4,372

 
$
2,912

 
$
1,460

 
 
 
 
 
 
Securities sold under agreement to repurchase (1)
$
571

 
$

 
$
571


______________
(1)
Excludes expense of $2 million in Securities sold under agreement to repurchase.
The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at June 30, 2019.
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At June 30, 2019
 
Gross Amount
Recognized
 
Gross Amount
Offset in the Balance Sheets
 
Net Amount
Presented in the
Balance Sheets
 
(in millions)
Assets:
 
 
 
 
 
Total derivatives
$
5,185

 
$
5,114

 
$
71

Other financial instruments
1,701

 

 
1,701

Other invested assets
$
6,886

 
$
5,114

 
$
1,772

 
 
 
 
 
 
Liabilities:
 
 
 
 
 
Total derivatives
$
5,114

 
$
5,089

 
$
25

Other financial liabilities
1,521

 

 
1,521

Other liabilities
$
6,635

 
$
5,089

 
$
1,546

Gross Collateral Amounts Not Offset in Consolidated Balance Sheets
The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at June 30, 2019.
Collateral Amounts Not Offset in the Consolidated Balance Sheets
At June 30, 2019
 
Net Amount Presented in the Balance Sheets
 
Collateral (Received)/Held
 
 
 
Financial
Instruments
 
Cash
 
Net
Amount
 
(in millions)
Assets:
 
 
 
 
 
 
Total derivatives
$
3,281

 
$
238

 
$
2,972

 
$
71

Other financial instruments
1,701

 

 

 
1,701

Other invested assets
$
4,982

 
$
238

 
$
2,972

 
$
1,772

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 

Total derivatives
$
25

 
$

 
$

 
$
25

Other financial liabilities
1,521

 

 

 
1,521

Other liabilities
$
1,546

 
$

 
$

 
$
1,546

The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2018.
Collateral Amounts Not Offset in the Consolidated Balance Sheets
At December 31, 2018
 
Net Amount Presented in the Balance Sheets
 
Collateral (Received)/Held
 
 
 
Financial Instruments
 
Cash
 
Net
Amount
 
(in millions)
Assets:
 
 
 
 
 
 
 
Total derivatives
$
1,397

 
$

 
$
(1,363
)
 
$
34

Other financial instruments
1,520

 

 

 
1,520

Other invested assets
$
2,917

 
$

 
$
(1,363
)
 
$
1,554

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Total derivatives
$
197

 
$

 
$

 
$
197

Other financial liabilities
1,263

 

 

 
1,263

Other liabilities
$
1,460

 
$

 
$

 
$
1,460

 
 
 
 
 
 
 
 
Securities sold under agreement to repurchase (1) (2) (3)
$
571

 
$
(588
)
 
$

 
$
(17
)
______________
(1)
Excludes expense of $2 million in Securities sold under agreement to repurchase.
(2)
U.S. Treasury and agency securities are in Fixed maturities available-for-sale on the consolidated balance sheets.
(3)
Cash is included in Cash and cash equivalents on consolidated balance sheets.
Repurchase Agreements Accounted for as Secured Borrowings
The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2018.
Repurchase Agreement Accounted for as Secured Borrowings
At December 31, 2018
 
Remaining Contractual Maturity of the Agreements
 
Overnight and Continuous
 
Up to 30 days
 
30–90 days
 
Greater Than 90 days
 
Total
 
(in millions)
Securities sold under agreement to repurchase (1):
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency securities
$

 
$
571

 
$

 
$

 
$
571

Total
$

 
$
571

 
$

 
$

 
$
571

______________
(1)
Excludes expense of $2 million in Securities sold under agreement to repurchase on the consolidated balance sheets.